AMANDA HIGGINS: Open Payments
NPI 1376183426 · SUN LAKES, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 52 payments from 18 companies in 2025. Trend: 2023 $953 · 2024 $1,102 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $173 |
| AstraZeneca Pharmaceuticals LP | 6 | $138 |
| GlaxoSmithKline, LLC. | 6 | $134 |
| Novo Nordisk Inc | 5 | $87 |
| Lilly USA, LLC | 5 | $83 |
| Amgen Inc. | 4 | $67 |
| Astellas Pharma US Inc | 2 | $47 |
| PFIZER INC. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| SANOFI PASTEUR INC. | 1 | $31 |
Products named: TRELEGY ELLIPTA, QULIPTA, FARXIGA, AIRSUPRA, EVENITY, UBRELVY, Veozah, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
